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Summary 26 
To study the prevalence of C. trachomatis and M. genitalium in a population of infertile 27 
couples from Iran and how this relates to tubal factor infertility, pregnancy rate and 28 
outcome of pregnancy. Blood, semen and first void urine samples were obtained from 250 29 
infertile couples and 250 fertile women as a control. Infertile couples were followed up after 30 
24 months to determine diagnosis, referral for assisted conception, any pregnancy and 31 
pregnancy outcome. Data were analyzed with regard to the results of(i) serological 32 
analysis for specific antibodies to C. trachomatis in serum; (ii) the presence of C. 33 
trachomatis and M. genitalium DNA in first void urine ; and (iii) in a semen sample of the 34 
male partner. Prevalence of C. trachomatis in our study population was comparable to 35 
other studies using similar methods and test specimens. No evidence of M. genitalium 36 
infection was found. Detection of C. trachomatis in one partner rarely correlated with 37 
infection in the other. The risk of tubal factor infertility and the probability of pregnancy and 38 
pregnancy outcome were unrelated to the results of serological tests for C. trachomatis 39 
antibodies or the presence of C. trachomatis DNA in first void urine of both partners and in 40 
a semen sample provided by the male. 41 
 42 
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INTRODUCTION 52 
Chlamydia trachomatis and Mycoplasma genitalium are bacterial infections of the male 53 
and female reproductive epithelium and are common causes of non-gonococcal urethritis 54 
(Taylor and Haggerty, 2011; McGowin et al., 2012).However, their prevalence depends on 55 
sex, age, sexual activity, study population, the test specimen taken and the diagnostic 56 
methods used (Dorey et al., 2012) leading to a confusing picture of their role in infertility. 57 
 58 
Of the two organisms, C. trachomatis that has been more extensively studied. There is 59 
controversy between results from a new systematic review in non-pregnant women and 60 
pregnant women. The studies showed results available for non-pregnant women are 61 
indicating test and treat of C. trachomatis infection in antenatal care to prevent adverse 62 
pregnancy and neonatal outcomes (de Cortina et al., 2016), another systematic review in 63 
pregnant women showed wide variation of  Sexually Transmitted Infection (STI) burden in 64 
pregnancy (Joseph Davey et al., 2106) and therefore further studies would be needed. 65 
C. trachomatis incidence in different studies has ranged from 52.8% when tested by PCR 66 
of endocervical samples from sub-fertile women in Brazil(de Lima Freitas et al., 2011) to 67 
as low as 1.0% in a population of asymptomatic subfertile women in Germany by PCR of 68 
urine samples(Eggert-Kruse et al., 2003).In male partners,C. trachomatis infection has 69 
ranged from 39.4% in Tunisia when detected by PCR in semen and first void urine 70 
samples(Gdoura et al., 2008) to 0.304% in a Canadian cohort study where both urine and 71 
semen samples were tested(Domes et al., 2012). Also a prospective cross-sectional study 72 
in 2013 showed the presence of chlamydial antibodies was quantitatively related to the 73 
likelihood of hysterosalpingography diagnosed tubal disease(Olaleye & Olamijulo, 2016). 74 
 75 
In contrast to C. trachomatis, the incidence of M. genitalium in infertile couples is not as 76 
well studied and moreover its prevalence as a STI is also highly variable. Although most 77 
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investigations have considered men with urethritis, in a single study the prevalence among 78 
male partners of infertile couples in Tunisia was found to be 18.3 %(Gdoura et al., 2008). 79 
By contrast, the incidence among infertile women with tubal factor infertility (TFI) was 80 
22.0% compared to 6.3% in women with no tubal abnormality detected(Clausen et al., 81 
2001).  82 
 83 
However, in the setting of a genitourinary medicine (GUM) clinic its incidence in women 84 
who were considered low risk was found to be as low as 5%and in high risk populations 85 
was 7.3%(McGowin and Anderson-Smits, 2011). 86 
 87 
Bacterial infections are of concern in men and women of reproductive age because of 88 
potential direct effects on conception. In women, for example, genital tract infection can 89 
give rise to Pelvic Inflammatory Disease (PID) and TFI (Haggerty et al., 2010). Whereas in 90 
men it has been shown that semen quality (Hosseinzadeh et al., 2000; Idahl et al., 2007) 91 
and sperm function (Hosseinzadeh et al., 2000; 2001; 2003; Eley et al., 2005) can be 92 
affected by past or current infection. Therefore, it might be hypothesized that the risk of 93 
TFI as well as the pregnancy rate and/or pregnancy outcome in couples with an active 94 
bacterial infection might be poorer than in those with no evidence of infection. 95 
 96 
To investigate this, we have examined the prevalence of C. trachomatis and M. genitalium 97 
infection in a population of couples from Iran seeking their first medical consultation for 98 
infertility. In addition, we also examine the pregnancy rate and outcome of pregnancy in 99 
relation to the diagnosis of C. trachomatis and M. genitalium in either partner. 100 
 101 
 102 
MATERIALS AND METHODS 103 
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Study population and samples obtained 104 
Sequential couples (n=324) attending the Research and Clinical Centre for Infertility (Yazd, 105 
Iran)presenting with primary and secondary infertility were screened for inclusion in the 106 
study between September 2009 and October 2010. All were approached with informed 107 
consent and were asked to participate unless one or both of them had: (i) abnormal 108 
karyotype; (ii) history of chemotherapy or radiotherapy treatment; (iii) previous sterilisation; 109 
(iv) low semen volume (<1.0 ml) or retrograde ejaculation in the male partner; (v) 110 
hypogonadotropic hypogonadism; (vi) a genital tract anomaly; or (vii) where the female 111 
age was >35 years old. Using these criteria, seventy-four couples were excluded and the 112 
remainder (n=250) were enrolled, with each partner giving informed consent. 113 
 114 
Two hundred and fifty pregnant women attending the antenatal clinic in the Akbary Public 115 
Health centre (Yazd, Iran) were recruited as a control group between May 2010 and 116 
September 2010. Only women with naturally conceived pregnancies, as recorded in 117 
medical records, were recruited and gave written informed consent to take part. Extensive 118 
attempts were also made to recruit fertile men but this was not successful. 119 
The Ministry of Health Research Ethics Committee, Iran and the University of Sheffield 120 
School Of Medicine Research Ethics Committee approved all recruitment procedures and 121 
the collection and processing of biological samples. 122 
 123 
Collection, processing and transport of samples 124 
All enrolled participants (each individual) provided a 2-ml blood sample (1.5-ml serum) and 125 
20-40 ml urine and the male partners provided a semen sample. Blood was collected into 126 
a tube without any anticoagulant and within 6 hours was centrifuged (blood was clotted) at 127 
1500 g for 10 minutes then the serum removed and stored at -20ºC.First void urine 128 
samples for both partners of infertile couples as well as the fertile controls were stored in a 129 
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refrigerator immediately after collection and DNA extraction (see below)was performed 130 
within 2 days. Ejaculates were produced after at least 48 hours sexual abstinence and 131 
semen samples were stored -80ºC prior to DNA extraction.DNA was extracted from all 132 
urine and semen samples using the QIAamp DNA Mini kit (Qiagen, Hilden, Germany) 133 
following the manufactureU¶s instruction. DNA was stored at -20ºC prior to transfer of 134 
specimens to the UK.Frozen sera and extracted DNA from urine and semen were 135 
transferred on dry ice to Sheffield at the end of the recruitment phase. Upon arrival in 136 
Sheffield the samples were stored at -20ºC prior to further analysis as outlined below. 137 
 138 
 139 
Chlamydia trachomatis serology 140 
To detect specific IgA, IgMand IgG antibodies to C. trachomatis an immunofluorescence 141 
assay (SeroFIATMC. trachomatis) kit was used (Savyon, Ashdod, Israel). Two people 142 
examined each slide and a positive resultdeclared when both were in agreement. Positive 143 
and negative controls on each slide were included from the kit. 144 
 145 
Chlamydia trachomatis PCR 146 
Nested plasmid PCR for C. trachomatis was conducted according to a previously 147 
published method on all extracted DNA from urine and semen and two pairs of primers 148 
(directed against the cryptic plasmid) used to detect C. trachomatis as previously 149 
described (Hosseinzadeh et al., 2004). Products were analyzed by gel electrophoresis in 150 
1.0% (w/v) agarose with ethidium bromide staining.Positive results were compared with C. 151 
trachomatis plasmid (pCTT1) sequence, accession: M19487 (J03304). 152 
 153 
 154 
Mycoplasma genitalium PCR 155 
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PCR was carried out on all urine and semen DNA samples to identify the M. genitalium 156 
16SrRNA gene (Jensen et al., 1991; 2003).The DNA template for positive control was 157 
supplied by the Health Protection Agency (London, UK), giving a band size of 427 bp,and 158 
distilled water used as a negative control.Products were analyzed by gel electrophoresis in 159 
0.8% (w/v) agarose with ethidium bromide staining. 160 
 161 
Clinical information 162 
Clinical information was collected from questionnaires and  medical records. Primary 163 
infertility was defined as the lack of conception after a year of unprotected coitus, whereas 164 
secondary infertility was defined as the inability of a couple to conceive after a year of 165 
unprotected and appropriately timed intercourse when one or both partners had previously 166 
conceived children (Shaw, 2003) . TFI was defined as the occlusion of one or both tubes 167 
as diagnosed either by laparoscopy and/or HSG (Patil, 2009). Endometriosis was 168 
confirmed by laparoscopy using European Society of Human Reproduction and 169 
Embryology(ESHRE) guidelines for diagnosis and treatment of endometriosis (Kennedy et 170 
al., 2005). PCOS was diagnosed by vaginal sonography and/or laparoscopy and 171 
considering hirsutism (hyperandrogenism) and oligo-amenorrhea in a general examination 172 
as described in the Rotterdam 2003 guidelines (Fauser et al., 2004). A regular menstrual 173 
cycle was defined as being 25-34 days. Miscarriage indicates loss of an embryo or fetus 174 
before the 20th week of pregnancy ( Shaw, 2003). 175 
 176 
Follow up 177 
During follow up period patients were followed up for 24 months after their enrolment into 178 
the study. Data collected from their medical records including the treatment and diagnostic 179 
procedure performed. 180 
8 
 
Follow up details included the outcome of any pregnancy (spontaneous or assisted) 181 
including live birth, still birth, miscarriage and ongoing pregnancy. Also the sex and weight 182 
of baby was born during follow up.  183 
 184 
The Statistical Package for the Social Sciences (SPSS) 18.0 software (SPSS Inc., 185 
Chicago, IL, USA) was used for data analysis. Chi-square test was employed to compare 186 
positivity of C. trachomatis by different tests between couples to show the concordance. 187 
Relative Risk (RR) and 95% Confidence Interval (95% CI) were used to find the 188 
relationship between past medical and reproductive history and infection. Logistic 189 
regression was used to examine confounding factors among clinical data obtained in the 190 
study population. 191 
 192 
RESULTS 193 
The age of all participants ranged from 15 to 52 years of age, with a median age for 194 
infertile males of 32 (range 21-52), for infertile women 28(range 15-35) and for fertile 195 
women (control group) 28 (range 16-39).The duration of infertility in each couple ZDV1 196 
year but in individual cases ranging up to 18 years. Primary infertility was seen in 72.8% of 197 
couples and secondary infertility was seen in 27.2%. The duration of infertility was 5.8 ± 198 
3.5 years among couples with primary infertility and 6.3 ± 3.6 (mean ± SD) years among 199 
couples with secondary infertility. None of the patients complained of any symptoms of on-200 
going sexually transmitted infections. Table 1a details the principle diagnoses 201 
encountered, with Table 1b showing the type of assisted conception undertaken and Table 202 
1c the proportion of couples achieving a pregnancy. After 24 months, 25 couples were still 203 
undergoing treatment. However, four couples (1.6%) had been divorced and 14 couples 204 
(5.6%) were  205 
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lost to follow-up, of whom 5 couples had emigrated and the rest did not respond or were 206 
unreachable. Therefore, pregnancy (end-point) data were only available for232/250 207 
(92.8%) of couples enrolled at the start of the study. 208 
 209 
In the infertile couples, the prevalence of C. trachomatis defined by serology (IgG positive) 210 
was 18% (45/250) and 15.6% (39/250) in male and female partners respectively.This 211 
compared to 12.8% observed in the fertile women. In only 9 couples were both partners 212 
IgG positive. No IgA positive samples were found in infertile couples or fertile women and 213 
only 1.2% (3/250) and 4% (10/250) of samples were IgM positive in infertile males and 214 
females.All serum samples from fertile controls were also tested for IgM and IgA but no 215 
positive samples were found. 216 
 217 
PCR of urine from infertile men and women were positive for C. trachomatis DNA in 218 
4.4%(11/250) and 4.8% (12/250) of cases. However, although the incidence seemed very 219 
similar between males and females in only one couple did the urine samples from both 220 
partners test positive. None of the semen samples from the male partners tested positive 221 
for C. trachomatis DNA. Similarly, PCR of the urine DNA from fertile women (n=250) did 222 
not find any evidence of C. trachomatis. 223 
 224 
In addition to PCR for evidence of C. trachomatis DNA, urine from each group and semen 225 
samples from male partners of infertile couples were also examined for evidence of M. 226 
genitalium DNA, but no samples were found to be positive. 227 
In total, 41 out of the 250 women in infertile partnerships (16.4%) were found to have one 228 
or both tubes blocked as diagnosed either by laparoscopy and/or HSG. Therefore, Table 2 229 
shows the risk of TFI according to the C. trachomatis status in either the female (Table 2a) 230 
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or male (Table 2b) partner. These data show that the risk of TFI was not associated with 231 
the C. trachomatis status in either partner, regardless of whether this was defined by PCR  232 
or serology (IgM&IgG). 233 
 234 
Table 3 shows the risk of women in infertile partnerships achieving a pregnancy either 235 
naturally (n=56) or following assisted conception (n=59) as a function of her (Table 3a) or 236 
KHU SDUWQHU¶V 7DEOH 3b) C. trachomatis status. Briefly, this shows that there was no 237 
relationship between pregnancy and C. trachomatis status in either partner. 238 
 239 
Table 4 shows data for pregnancy outcome (live birth or pregnancy loss) in the 115 240 
couples for which outcome data was available. There was no relationship between 241 
pregnancy outcome and C. trachomatis status in either partner as assessed by serology 242 
(IgM&IgG) and PCR of first void urine. 243 
DISCUSSION 244 
We aimed to determine the prevalence of C. trachomatis and/or M. genitalium among a 245 
population of infertile couples in provincial Iran and relate this information to their 246 
probability of pregnancy (natural or through assisted conception)and the outcome of 247 
pregnancy (live birth or pregnancy loss). To our knowledge, this is the first study of 248 
prevalence undertaken on infertile couples in Iran using PCR and serology. Moreover, this 249 
is only the second study we are aware of at any location to examine the relationship 250 
between prevalence and outcome data in such a cohort. 251 
 252 
In contrast with other studies this study did not support the relationship between C. 253 
trachomatis infection and TFI. Our other main findings are low prevalence of C. 254 
trachomatis ( comparable to other studies), a zero incidence of M. genitalium.  255 
 256 
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C. trachomatis infection by IgA antibodies in serum detect signs of early infection, 257 
(Hamdad-Daudi et al., 2004) and serum IgM and PCR of first void urine establish current 258 
infection (Hamdad-Daudi et al., 2004; Eggert-Kruse et al., 2011) and serum IgG provides 259 
evidence of past infection (Hamdad-Daudi et al., 2004). As anticipated, a higher 260 
prevalence of C. trachomatis IgG antibodies was observed in both male and female 261 
partners of infertile couples, compared to women of proven fertility (control group).The 262 
prevalence of serum IgM and DNA positive samples was about three times lower than 263 
seen for IgG. However, overall these data were similar to rates found in non-Islamic 264 
countries of Europe and North America when like-for-like comparisons for test and test-265 
specimen are made. 266 
 267 
In Sweden the prevalence of IgG antibodies was 24.2% for women and 20.1% for men 268 
presenting as couples for infertility and 15.6% for pregnant women acting as controls 269 
(Idahl et al., 2004).Similarly, the prevalence of C. trachomatis DNA in first void urine of 270 
infertile couples was lower, at 6.8% and 7.1% for the female and male partner respectively 271 
(there was no first void urine available for the pregnant women acting as controls). In 272 
contrast, only 4.5% of French males from infertile couples had detectable levels of IgG 273 
antibodies in serum and C. trachomatis DNA was detected in 5.4% of first void urine 274 
samples (Hamdad-Daoudi et al., 2004). 275 
 276 
Interestingly, in our population there was no evidence of concordance within couples with 277 
regard to C. trachomatis infection. This was unexpected and is in contrast with previous 278 
studies although that may represent differences in the populations studied and the testing 279 
strategies used to detect current or past infection. In a study of infertile couples a 280 
significant relationship between IgG positivity in the male and female partner was reported, 281 
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and as well as a significant correlation between their serum IgG titre levels (Idahl et al., 282 
2004). 283 
 284 
In addition, we failed to find evidence of C. trachomatis or DNA in semen samples 285 
provided by the male partner or any evidence of M. genitaliumin any urine or semen 286 
samples tested. Whilst this may reflect problems with our PCR, we think this unlikely since 287 
the positive and negative controls worked as expected. The prevalence of M. genatalium 288 
in infertile couples has to our knowledge not been studied. In infertile women, antibodies to 289 
M. genitalium were found in 22% of their patients with TFI (Clausen et al., 2001).This is 290 
similar to an investigation on women in Kenya with endometritis (16%)  (Cohen, 2002) and 291 
women in the United Kingdom with clinically suspected PID (13%) (Simms, 2003). It 292 
remains possible therefore, that M. genitalium is a rare infection in infertile couples in this 293 
part of Iran. However, a recent study in Tehran found a prevalence of 12% and 2% in 294 
symptomatic and asymptomatic men respectively using PCR of first void urine (Yeganeh 295 
et al., 2013). Clearly, this is an area which requires further investigation. 296 
Given the prevalence of C. trachomatis seen in the infertile couples recruited to this study, 297 
we were surprised that there were no negative relationships between past or current C. 298 
trachomatis infection and TFI or the probability of pregnancy (either natural or with 299 
assisted conception) and/or pregnancy outcome (live birth or pregnancy loss) in those 300 
women who did get pregnant. A study similar in design to ours found that IgG antibodies in 301 
women was related to TFI, but that decreased pregnancy rates were only seen in couples 302 
where the man was IgG positive (Idahl et al., 2004). The difference between the two 303 
studies is hard to explain given they recruited a similar number of couples (n=250 vs. 304 
n=244), had similar levels of serum IgG antibodies to C. trachomatis (24.2% vs. 15.6% in 305 
infertile women and 20.1% vs. 18.0% in infertile men) and a similar incidence of TFI 306 
(16.4% in this study vs. 19%(Idahl et al., 2004).  However, both studies have found that 307 
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among couples that did achieve a pregnancy, pregnancy outcome was unrelated to past 308 
C. trachomatis infection in either partner (i.e. IgG positive) although we can also conclude 309 
from our PCR results that pregnancy outcome was also unrelated to current C. 310 
trachomatis infection. This is strengthened by the fact that, unlike the study by Idahl and 311 
colleagues (Idahl et al., 2004). where presumably the results of serological tests were 312 
available quickly ± our couples were not given antibiotic therapy, since the nature of 313 
recruitment (in Iran) and subsequent analysis in Sheffield (up to two years later) meant 314 
that most /all patients had concluded the follow-up period before the results of screening 315 
tests were known. Therefore, if current infection were an important determinant in the 316 
probability of pregnancy or pregnancy outcome, we would argue that it would be more 317 
obvious in the current study than the one previously conducted (Idahl et al., 2004). 318 
 319 
 320 
Although previous studies suggesting a relationship between C. trachomatis antibodiesand 321 
TFI (Taylor and Haggerty, 2011; Clausen et al., 2001;Idahl et al., 2004).,[1, 8, 25]most 322 
were carried out on women based on a positive result for C. trachomatis and/ora medical 323 
history of TFI. In our study, women were not symptomatic and the serology results were 324 
obtained after patient recruitment and the completion of all diagnostic procedures. 325 
Therefore recruitment was carried out blind to diagnosis and without reference to their 326 
diagnosis or reason for infertility. Among 41 women with a TFI diagnosis, only 6 female 327 
and 9 male partners were IgG positive, with only one couple where both partners were IgG 328 
positive. The rest (26 women) were negative for IgG antibody to chlamydia. Therefore, we 329 
feel confident that this is a genuine result and worthy of reporting. 330 
 331 
Although clinical guidelines suggest C. trachomatis screening is vital, authors have 332 
questioned the strength of the evidence base to suggest that genital chlamydial infection 333 
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leads to infertility. A systematic review of 3,349 studies published in this journal concluded 334 
WKHUH ZDV DQ µDEVHQFH RI YDOLd evidence on the attributable risk of post-infective tubal 335 
factor infertility aftHUJHQLWDOFKODP\GLDOLQIHFWLRQ¶ (Wallace et al., 2008).This has been given 336 
subsequent credence by modelling studies (Kavanagh et al., 2013), which have suggested 337 
WKDW µDW WKHSRSXODWLRQ OHYHO WKH OLNHOLKRRGRIDOO-cause TFI in those with past or current 338 
FKODP\GLDOLQIHFWLRQLVORZ¶ Clearly this remains a controversial area where well-conducted 339 
population based studies are still required. 340 
 341 
In conclusion, our findings suggest that in a population of infertile couples in Iran, current 342 
or pastC. trachomatis infection had little bearing on TFI and moreover had no influence on 343 
the chance of pregnancy or pregnancy outcome in those who conceived. With regard to M. 344 
genitalium, we can find no evidence of a relationship with infertility and pregnancy 345 
outcome by virtue of the fact that no evidence of infection could be found. 346 
 347 
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 496 
Table 1: Diagnoses, treatment and outcome summary of the infertile women (n=250) after 497 
24 months follow up. 498 
 No of couples Percent (%) 
(a) Principal diagnoses:   
Male Factor 100 40.0 
PCOS 56 22.4 
Tubal damage 41 16.4 
Unexplained 31 12.4 
Oligomenorrhea 30 12.0 
Endometriosis 22 8.8 
   
(b) Treatments:   
None 64 25.6 
Ovulation Induction 63 25.2 
IUI 18 7.2 
IVF 39 15.6 
ICSI 66 26.4 
   
(c) Pregnancy outcomes:   
Spontaneous 56 48.7 
Assisted Conception 59 51.3 
 499 
Table 2: The probability of tubal factor infertility (TFI) in 41 women according toC. 500 
trachomatis antibodies (IgM / IgG) in serum and detection of C. trachomatis DNA in urine 501 
in both the (a) female and (b) male partner. 502 
 503 
 504 
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(a) Female C. trachomatis status (b) Male C. trachomatis status 
Diagnosis TFI 
Status 
RR 
(95% CI) 
Diagnosis Partners 
TFI 
RR 
(95% CI) 
IgM Positive 2/10 1.23 (0.34-4.39) IgM 
Positive 0/3 1.45 
(0.26-8.11) Negative 39/240 Negative 41/247 
DNA Positive 0/12 0.47 (0.07-3.16) DNA 
Positive 2/11 1.11 
(0.31-4.03) Negative 41/238 Negative 39/239 
IgG Positive 6/39 0.93 (0.41-2.05) IgG 
Positive 9/45 1.28 
(0.66-2.49) Negative 35/211 Negative 32/205 
 505 
 506 
 507 
Table 3:Chances of achieving a pregnancy either naturally (n=56) or by Assisted 508 
Conception (n=59) in 232 sub-fertile couples according to the presence of IgM&IgG 509 
antibodies to C. trachomatisor the presence of C. trachomatis DNA detected by PCR of 510 
first void urine in either the (a) female or (b) male partner. 511 
 512 
 513 
  No of pregnancies RR (95%CI) 
  Natural 
conception 
Assisted 
conception 
Natural 
conception 
Assisted 
conception 
 
(a) Female partner: 
    
IgM Positive 1/9 3/9 0.45 (0.07-2.90) 
1.33 
(0.51-3.44) Negative 55/223 56/223 
DNA Positive 4/11 1/11 1.54 (0.68-3.49) 
0.35 
(0.05-2.27) Negative 52/221 58/221 
IgG Positive 11/39 13/39 1.21 (0.69-2.12) 
1.39 
(0.84-2.33) Negative 45/193 46/193 
 
(b) Male partner:     
IgM Positive 0/2 1/2 1.35 (0.27-6.79) 
1.98 
(0.49-8.07) Negative 56/230 58/230 
DNA Positive 4/10 2/10 1.71 (0.77-3.78) 
0.78 
(0.22-2.75) Negative 52/222 57/222 
IgG Positive 14/44 12/44 1.42 (0.86-2.37) 
1.09 
(0.63-1.88) Negative 42/188 47/188 
 514 
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Table 4:C. trachomatis antibodies (IgM&IgG) and the presence of C. trachomatis DNA detected by PCR of first void urinePCR in the (a) 515 
female and (b) male partner showing the relationship between live birth and pregnancy loss in naturalor assisted conception pregnancies. 516 
(a)  Pregnancy Outcome RR (95% CI) 
  
Natural conception or Assisted Conception Natural conception or Assisted Conception 
  Live birth 
 
Pregnancy loss Live birth 
 
Pregnancy loss 
IgM Positive 3/9 1/9 0.59 (0.23-1.53) 
0.69 
(0.10-4.63) Negative 59/106 17/106 
DNA Positive 4/11 0/11 0.65 (0.29-1.45) 
0.46 
(0.07-3.14) Negative 58/104 18/104 
IgG Positive 13/39 4/39 0.52 (0.32-0.83) 
0.56 
(0.19-1.58) Negative 49/76 14/76 
 517 
(b)  Pregnancy Outcome RR (95% CI) 
  
Natural conception or Assisted Conception Natural conception or Assisted Conception 
  Live birth 
 
Pregnancy loss Live birth 
 
Pregnancy loss 
IgM Positive 1/2 0/2 0.93 (0.23-3.74) 
1.03 
(0.08-13.34) Negative 61/113 18/113 
DNA Positive 3/10 0/10 0.53 (0.20-1.39) 
0.51 
(0.07-3.43) Negative 59/105 18/105 
IgG Positive 17/44 1/44 0.61 (0.40-0.92) 
0.09 
(0.01-0.69) Negative 45/71 17/71 
 518 
 519 
